Merial Introduces Treatment For Respiratory Disease In Cattle



Published:

Zactran can be used for control of BRD in high-risk cattle or as a first-pull treatment of sick cattle.

Merial today announced the U.S. launch of Zactran, an antimicrobial used to treat bovine respiratory (BRD) disease.

Zactran is available by prescription only and was specifically developed to treat BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle, as well as to control respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with M.haemolytica and P. multocida.
Two key features of the product, officials said, are its response time and duration of efficacy. Zactran provides response in 24 hours and has a 10-day duration of efficacy in a single dose, according to Merial.

“BRD causes between $800 to $900 million annually in economic losses from death, reduced feed efficiency and treatment costs,” said Bruce Nosky, DVM, manager of Merial’s Large Animal Veterinary Services. “Given the significant impact of BRD, veterinarians need cattle to respond quickly to treatment.”

Company officials said it began shipping the product, which comes in 100mL, 250mL and 500mL bottle sizes, to veterinarian distributors this week. They will announce specific pricing to veterinarians, who will price it accordingly to their clients. The price will be competitive with other BRD antimicrobial products on the market, according to the company.

Zactran has been available in Canada since 2010 and Europe since 2008.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Two Suspects Arrested for Veterinarian's Death

Cynthia Campbell Eason, DVM, was murdered by her stepson and friend, according to police.

Midmark Animal Health Announces 'Bring It!' Promotion

Veterinary professionals who purchase certain equipment can receive a free anesthesia-monitoring course worth 4 hours of CE credit.

OVC Takes Part in Bone Cancer Clinical Trial

The University of Guelph’s Ontario Veterinary College is taking part in a clinical trial headed by the U.S. National Cancer Institute’s Comparative Oncology Trials Consortium, the first such collaboration between the two groups.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module